Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://dx.doi.org/10.2174/1389201023666220429121953 http://hdl.handle.net/11449/246806 |
Resumo: | Background: Hemorrhagic cystitis is an inflammatory complication that can be caused by the administration of cyclophosphamide, which is widely used as an antineoplastic agent. In the search for new therapeutic alternatives, probiotics can suppress the inflammatory process and, there-fore, can be used to prevent this disease. Objective: Thus, this study aimed to evaluate the effects of using Lactobacillus acidophilus NCFM in the treatment of cyclophosphamide-induced hemorrhagic cystitis in Wistar rats. Methods: Lactobacillus acidophilus NCFM (2x108 CFU) was used in the treatment of cyclophos-phamide-induced hemorrhagic cystitis (200 mg/kg, intraperitoneal) in 77 female Wistar rats. Rats were distributed into experimental groups (n = 9): control group (GC), zero control group (GCZ), inflammation group (GI), 24-hour acute treatment groups: 24-hour lactobacilli treatment group (GL24H) and mesna group (GM), and 30-day chronic treatment groups: lactobacilli treatment group (GTL) and mesna+lactobacilli group (GM+L). After treatment, animals were euthanized and biological materials were collected for blood count, biochemical analyses, examination of abnormal sedi-ment elements (EAS), and histopathological analysis. Results: GI results showed development of edema, macroscopic alterations, and signs of bleeding in the bladder; in addition, lesions in the urothelium and hemorrhage were also found. GL24H and GM presented intact urothelium, without inflammatory reaction and hematological or biochemical urine alterations. Conclusion: Therefore, this study demonstrated that L. acidophilus presented uroprotective effect against the action of cyclophosphamide in both the short and long term. |
id |
UNSP_a439a82e7d951f7e68e5d9cb7a573ae9 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/246806 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Ratsbladder inflammationcyclophosphamideHemorrhagic cystitisLactobacillus sppprobioticswistar ratsBackground: Hemorrhagic cystitis is an inflammatory complication that can be caused by the administration of cyclophosphamide, which is widely used as an antineoplastic agent. In the search for new therapeutic alternatives, probiotics can suppress the inflammatory process and, there-fore, can be used to prevent this disease. Objective: Thus, this study aimed to evaluate the effects of using Lactobacillus acidophilus NCFM in the treatment of cyclophosphamide-induced hemorrhagic cystitis in Wistar rats. Methods: Lactobacillus acidophilus NCFM (2x108 CFU) was used in the treatment of cyclophos-phamide-induced hemorrhagic cystitis (200 mg/kg, intraperitoneal) in 77 female Wistar rats. Rats were distributed into experimental groups (n = 9): control group (GC), zero control group (GCZ), inflammation group (GI), 24-hour acute treatment groups: 24-hour lactobacilli treatment group (GL24H) and mesna group (GM), and 30-day chronic treatment groups: lactobacilli treatment group (GTL) and mesna+lactobacilli group (GM+L). After treatment, animals were euthanized and biological materials were collected for blood count, biochemical analyses, examination of abnormal sedi-ment elements (EAS), and histopathological analysis. Results: GI results showed development of edema, macroscopic alterations, and signs of bleeding in the bladder; in addition, lesions in the urothelium and hemorrhage were also found. GL24H and GM presented intact urothelium, without inflammatory reaction and hematological or biochemical urine alterations. Conclusion: Therefore, this study demonstrated that L. acidophilus presented uroprotective effect against the action of cyclophosphamide in both the short and long term.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Department of Health Sciences Faculty of Health Sciences Federal University of Grande Dourados (UFGD)Department of structural and functional biology Faculty of General and Applied Biology “Julio de Mesquita Filho” São Paulo State University (UNESP)Department of Clinical Biochemistry Faculty of Biomedicine University Center of Grande Dourados (UNIGRAN)Department of structural and functional biology Faculty of General and Applied Biology “Julio de Mesquita Filho” São Paulo State University (UNESP)Federal University of Grande Dourados (UFGD)Universidade Estadual Paulista (UNESP)University Center of Grande Dourados (UNIGRAN)Minhos, Liandra Ferreirade Lima Gehlen, Ana Cláudia da Silva [UNESP]Júnior, Felipe Francisco BittencourtDos Santos, Ariany CarvalhoSouza, Roosevelt Isaias Carvalhode Barros, Márcio Eduardo2023-07-29T12:51:00Z2023-07-29T12:51:00Z2023-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article438-449http://dx.doi.org/10.2174/1389201023666220429121953Current Pharmaceutical Biotechnology, v. 24, n. 3, p. 438-449, 2023.1873-43161389-2010http://hdl.handle.net/11449/24680610.2174/13892010236662204291219532-s2.0-85147823676Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengCurrent Pharmaceutical Biotechnologyinfo:eu-repo/semantics/openAccess2023-07-29T12:51:00Zoai:repositorio.unesp.br:11449/246806Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T15:49:42.489283Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats |
title |
Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats |
spellingShingle |
Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats Minhos, Liandra Ferreira bladder inflammation cyclophosphamide Hemorrhagic cystitis Lactobacillus spp probiotics wistar rats |
title_short |
Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats |
title_full |
Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats |
title_fullStr |
Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats |
title_full_unstemmed |
Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats |
title_sort |
Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats |
author |
Minhos, Liandra Ferreira |
author_facet |
Minhos, Liandra Ferreira de Lima Gehlen, Ana Cláudia da Silva [UNESP] Júnior, Felipe Francisco Bittencourt Dos Santos, Ariany Carvalho Souza, Roosevelt Isaias Carvalho de Barros, Márcio Eduardo |
author_role |
author |
author2 |
de Lima Gehlen, Ana Cláudia da Silva [UNESP] Júnior, Felipe Francisco Bittencourt Dos Santos, Ariany Carvalho Souza, Roosevelt Isaias Carvalho de Barros, Márcio Eduardo |
author2_role |
author author author author author |
dc.contributor.none.fl_str_mv |
Federal University of Grande Dourados (UFGD) Universidade Estadual Paulista (UNESP) University Center of Grande Dourados (UNIGRAN) |
dc.contributor.author.fl_str_mv |
Minhos, Liandra Ferreira de Lima Gehlen, Ana Cláudia da Silva [UNESP] Júnior, Felipe Francisco Bittencourt Dos Santos, Ariany Carvalho Souza, Roosevelt Isaias Carvalho de Barros, Márcio Eduardo |
dc.subject.por.fl_str_mv |
bladder inflammation cyclophosphamide Hemorrhagic cystitis Lactobacillus spp probiotics wistar rats |
topic |
bladder inflammation cyclophosphamide Hemorrhagic cystitis Lactobacillus spp probiotics wistar rats |
description |
Background: Hemorrhagic cystitis is an inflammatory complication that can be caused by the administration of cyclophosphamide, which is widely used as an antineoplastic agent. In the search for new therapeutic alternatives, probiotics can suppress the inflammatory process and, there-fore, can be used to prevent this disease. Objective: Thus, this study aimed to evaluate the effects of using Lactobacillus acidophilus NCFM in the treatment of cyclophosphamide-induced hemorrhagic cystitis in Wistar rats. Methods: Lactobacillus acidophilus NCFM (2x108 CFU) was used in the treatment of cyclophos-phamide-induced hemorrhagic cystitis (200 mg/kg, intraperitoneal) in 77 female Wistar rats. Rats were distributed into experimental groups (n = 9): control group (GC), zero control group (GCZ), inflammation group (GI), 24-hour acute treatment groups: 24-hour lactobacilli treatment group (GL24H) and mesna group (GM), and 30-day chronic treatment groups: lactobacilli treatment group (GTL) and mesna+lactobacilli group (GM+L). After treatment, animals were euthanized and biological materials were collected for blood count, biochemical analyses, examination of abnormal sedi-ment elements (EAS), and histopathological analysis. Results: GI results showed development of edema, macroscopic alterations, and signs of bleeding in the bladder; in addition, lesions in the urothelium and hemorrhage were also found. GL24H and GM presented intact urothelium, without inflammatory reaction and hematological or biochemical urine alterations. Conclusion: Therefore, this study demonstrated that L. acidophilus presented uroprotective effect against the action of cyclophosphamide in both the short and long term. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-07-29T12:51:00Z 2023-07-29T12:51:00Z 2023-01-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.2174/1389201023666220429121953 Current Pharmaceutical Biotechnology, v. 24, n. 3, p. 438-449, 2023. 1873-4316 1389-2010 http://hdl.handle.net/11449/246806 10.2174/1389201023666220429121953 2-s2.0-85147823676 |
url |
http://dx.doi.org/10.2174/1389201023666220429121953 http://hdl.handle.net/11449/246806 |
identifier_str_mv |
Current Pharmaceutical Biotechnology, v. 24, n. 3, p. 438-449, 2023. 1873-4316 1389-2010 10.2174/1389201023666220429121953 2-s2.0-85147823676 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Current Pharmaceutical Biotechnology |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
438-449 |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
|
_version_ |
1808128569560268800 |